Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin and Ezetimibe Effects on Lipoproteins and Inflammation
NCT02304926Completed
- Start
- Jan 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
01
Overview
Randomised trial of ezetimibe in dyslipidemia (2 arms). Primary endpoints: Total Cholesterol at 8 weeks, Low-density Lipoprotein Cholesterol at 8 weeks and 5 more. Started Jan 2009; status: completed.
02
Drugs
ezetimibe
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT02304926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02304926.